<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>DSpace Coleção:</title>
  <link rel="alternate" href="http://repositorio.ufc.br/handle/riufc/394" />
  <subtitle />
  <id>http://repositorio.ufc.br/handle/riufc/394</id>
  <updated>2026-04-03T07:49:38Z</updated>
  <dc:date>2026-04-03T07:49:38Z</dc:date>
  <entry>
    <title>Células dendríticas foliculares: avaliação imunofenotípica no linfoma de Hodgkin clássico subtipo esclerose nodular</title>
    <link rel="alternate" href="http://repositorio.ufc.br/handle/riufc/85405" />
    <author>
      <name>Almeida, Juliêta Maria Mendes Frota de</name>
    </author>
    <id>http://repositorio.ufc.br/handle/riufc/85405</id>
    <updated>2026-03-20T13:24:33Z</updated>
    <published>2004-01-01T00:00:00Z</published>
    <summary type="text">Título: Células dendríticas foliculares: avaliação imunofenotípica no linfoma de Hodgkin clássico subtipo esclerose nodular
Autor(es): Almeida, Juliêta Maria Mendes Frota de
Abstract: The follicular dendritic cells are the most important antigen presenting cells and have&#xD;
an important role in B cell immune response. Classic Nodular Sclerosis Hodgkin's&#xD;
Lymphoma (CNSHL) is a lymphoid neoplasm, more specifically from germinal center&#xD;
(GC) B cells, presenting with aggregates of follicular dendritic cells (FDC),&#xD;
Hodgkin/Reed Sternberg cells and variants and B cells forming complexes related to&#xD;
the GC, suggesting an association between nodular sclerosis and germinal center&#xD;
formation. CNSHL represents 70% of classic Hodgkin's lymphomas and has a&#xD;
favorable prognosis. Histologically it is characterized by a nodular pattern, collagen&#xD;
bands and lacunar cells. The goal of this study was the evaluation of the follicular&#xD;
dendritic cell by immunophenotyping with pS100 and fascin, in lymph node or&#xD;
mediastinal mass biopsies from patients with previously diagnosed classic nodular&#xD;
sclerosis Hodgkin's Lymphoma, trying to identify criteria as prognostic factors. 159&#xD;
charts were reviewed and 38 patients were selected for the study. From the selected&#xD;
group 55.2% were males with a male to female ratio of 1.23:1 and a median age of&#xD;
29.3 years. 52.6% were in clinical stage 1-11 and 68.4% had systemic symptoms (B).&#xD;
Multiple or isolated peripheral adenomegaly was present in all cases. The first lymph&#xD;
node site was cervical in 58% of the cases. 38 biopsy specimens were analysed and&#xD;
57.9% were of nodular sclerosis subtype II. Immunohistochemistry showed 100%&#xD;
positivity for CD30 and 68.4% for CD15. The follicular dendritic cells were identified&#xD;
by pS100 and fascin antibodies through the Peroxidase-antiperoxidase Streptavidin&#xD;
avidin-biotin indirect immunoenzimatic technique, which was performed in pre-treated&#xD;
slides with the biopsy specimens included in paraffin blocks. The marking with pS100&#xD;
didn't show good visualization of the network of follicular dendritic cells, and was&#xD;
useful as a generic marker. Fascin was the gold-standard for follicular dendritic cells,&#xD;
showing its positivity by the brown color. The CDF1 pattern was present in 7.9%,&#xD;
CDF2 in 47.4% and CDF3 in 44.7%. There was no relation between the presence of&#xD;
the follicular dendritic cell and sex, age, clinical stage, laboratorial parameters, or&#xD;
response to treatment, but a tendency for the association (p=0.056) between the&#xD;
subtypes of classical nodular sclerosis Hodgkin's lymphoma was demonstrated. The&#xD;
patients with follicular dendritic cells present in their biopsies have been watched for&#xD;
a longer period of time of about 32.9 months. This enabled a significant statistical&#xD;
association (p=0.001) between the presence of follicular dendritic cells and length of&#xD;
follow-up
Tipo: Dissertação</summary>
    <dc:date>2004-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Avaliação da contratilidade e do estresse oxidativo em íleo e cólon e análise proteômica do plasma de camundongos C57BL6J expostos ao metilmercúrio</title>
    <link rel="alternate" href="http://repositorio.ufc.br/handle/riufc/84399" />
    <author>
      <name>Buzaglo, Alexander Vasconcelos</name>
    </author>
    <id>http://repositorio.ufc.br/handle/riufc/84399</id>
    <updated>2026-01-21T16:07:23Z</updated>
    <published>2025-01-01T00:00:00Z</published>
    <summary type="text">Título: Avaliação da contratilidade e do estresse oxidativo em íleo e cólon e análise proteômica do plasma de camundongos C57BL6J expostos ao metilmercúrio
Autor(es): Buzaglo, Alexander Vasconcelos
Abstract: Methylmercury (MeHg) is an organic mercury (Hg) compound with high toxicity due&#xD;
to its easy absorption after exposure. MeHg rapidly distributes throughout all tissues, crossing&#xD;
the blood-brain barrier and the epithelial barrier in the central nervous system and&#xD;
gastrointestinal tract, respectively, and can lead to a wide range of debilitating symptoms and&#xD;
death. The aim of this study was to elucidate the effects of oral methylmercury chloride&#xD;
exposure on body weight gain, intestinal motility, oxidative stress, and the proteomic profile&#xD;
in the plasma of intoxicated animals compared with the control group. For this purpose, 46&#xD;
adult male C57BL6 mice from the animal facility of the Drug Development Center (NPDM)&#xD;
under pathogen-free conditions were used. Mice aged 60 to 90 days with body weights&#xD;
between 15 and 20 g, were divided into two groups: the control group receiving a saline&#xD;
solution by gavage and the intoxicated group receiving a methylmercury chloride solution (2&#xD;
mg/kg diluted in saline) by gavage for 14 consecutive days. All animals were weighed every&#xD;
3 days. Seven days after the end of intoxication, the animals were euthanized, and samples of&#xD;
hair, blood, duodenum, ileum, and colon were collected. Quantification of Hg in the hair,&#xD;
evaluation of ileum and colon contractility ex vivo, in a bath chamber for isolated tissues&#xD;
after exposure to potassium chloride (20-160 mM) and carbachol (0.1-100μM), evaluation of&#xD;
oxidative stress in the ileum and colon (tissue concentrations of glutathione-GSH,&#xD;
malondialdehyde-MDA and catalase-CAT) and proteomic analysis of plasma were&#xD;
performed. A significant reduction in the curve of percentage weight gain (% of initial&#xD;
weight) (p&lt;0.05) when compared to the control group. Furthermore, elevated Hg levels in the&#xD;
hair were observed in the intoxicated group compared to the control group (Difference&#xD;
between means ± SEM: 6067 ± 2180). There was no significant difference in intestinal&#xD;
contractility in the ileum or colon between the groups. A significant increase in GSH was&#xD;
detected in the colon and a significant increase of CAT in the ileum of intoxicated animals&#xD;
(p=0.05). Significant alterations were observed in the proteomics analyses between groups,&#xD;
notably an increase in the expression of apolipoproteins E and H and a reduction in&#xD;
phosphatidylcholinesterol acetyltransferase, suggesting metabolic alterations; an increase in&#xD;
the expression of complement factor I, the Mu constant of the heavy chain and the C region&#xD;
of the Ig alpha chain, and a reduction in the C9 and C4b components of the complement&#xD;
system, suggesting a systemic response. We also observed an increase in the expression of&#xD;
the fibrinogen alpha chain and coagulation factor X and a reduction in the expression of the&#xD;
fibrinogen beta chain, suggesting altered liver function and prothrombotic conditions; a&#xD;
reduction in selenoprotein P, expected in models of mercury intoxication without selenium&#xD;
supplementation, indicating deficiencies in this element caused by mercury intoxication; and&#xD;
a reduction in peroxiredoxin 2 levels, that may affect the net antioxidant capacity. In&#xD;
summary, these results corroborate the known deleterious effects of mercury toxicity on the&#xD;
intestinal tract and contribute to the identification of potential proteomic biomarkers. Further&#xD;
studies are needed to confirm these findings, especially in clinical trials.
Tipo: Dissertação</summary>
    <dc:date>2025-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Síndromes mielodisplásticas   [manuscrito] :  caracterizacão morfológica e imunohistoquímica quanto a expressão da proteína p 53</title>
    <link rel="alternate" href="http://repositorio.ufc.br/handle/riufc/83860" />
    <author>
      <name>Magalhães, Silvia Maria Meira</name>
    </author>
    <id>http://repositorio.ufc.br/handle/riufc/83860</id>
    <updated>2025-12-12T16:21:30Z</updated>
    <published>1997-01-01T00:00:00Z</published>
    <summary type="text">Título: Síndromes mielodisplásticas   [manuscrito] :  caracterizacão morfológica e imunohistoquímica quanto a expressão da proteína p 53
Autor(es): Magalhães, Silvia Maria Meira
Abstract: Summary&#xD;
The p53 gene is currenuy thought to be a tumor suppressor gene, and its alterauons&#xD;
have been suggested to be involved m the pathogenesis of several human malignajicies.&#xD;
The piirpose of fhe present study was fhe evaluation of histológica! findings and&#xD;
the uiununohistochemical study ofp53 egression on bone marrow biopsy from uiirty-&#xD;
three patients in which a myelodysplasuc syndrome (MDS) was diagnosed. Forty-&#xD;
three bone marrow biopsies were reü-ospecüvely reviewed, and relationship among&#xD;
the different histological parajmeters as weU as clinicopafhological correlations were&#xD;
looked for.&#xD;
Histological analysis showed in 78,8% of cases a hypercellular, in 12,1% a&#xD;
hypocellular and in 9,1% a norniocellular bone marrow. Dysraegakaryopoiesis was&#xD;
the inost prominent abnormality of the hematopoietic series, detected in 72,7% of&#xD;
cases. Abnormal localization of immature precursors occurred in 39,4% of patients&#xD;
and increase in reticulin fibers occurred in 34,4%. The frequency oflymphoid nodules&#xD;
in our cases (27.3%) was higher fhan that reported by others with no relauonship&#xD;
with age, but significanuy related to Üückenmg of Uie reticulin network . Nuclear&#xD;
accumulaüon ofp53 protein was foimd m 15,2% offhe cases whereas control subjects&#xD;
were imiformly negaüve for p53 protein. All the five MDS cases that exhibited positive&#xD;
p53 reaction had some kind of disease progression, namely a more advanced FAB&#xD;
subtype and/or acute leukenua. A p53 immunoreactivity was therefore significanuy&#xD;
related to biological aggressiveness and progression of the disease.&#xD;
The results suggest that p53 mutauons may contribute, albeit rarely, to the&#xD;
development of MDS and, once present, may confer a growth advantage to myeloid&#xD;
cells and therefore is useful for predicting the evoluüon. MDS is heterogeneous not&#xD;
only in its phenotype but also in the Kciolecular niechanism of its genesis and&#xD;
progression. More extended and detailed study is necessary to understand the&#xD;
molecular basis of MDS development. The major aim is a more specific and effective&#xD;
treatment of these pauents.
Tipo: Dissertação</summary>
    <dc:date>1997-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Aplicações clínicas de sequenciamento de nova geração: da genômica em neuropsiquiatria ao desenvolvimento de um protocolo de metagenômica clínica no Ceará</title>
    <link rel="alternate" href="http://repositorio.ufc.br/handle/riufc/83164" />
    <author>
      <name>Silva, Carlos Antônio de Arroxelas</name>
    </author>
    <id>http://repositorio.ufc.br/handle/riufc/83164</id>
    <updated>2025-10-20T22:50:43Z</updated>
    <published>2025-01-01T00:00:00Z</published>
    <summary type="text">Título: Aplicações clínicas de sequenciamento de nova geração: da genômica em neuropsiquiatria ao desenvolvimento de um protocolo de metagenômica clínica no Ceará
Autor(es): Silva, Carlos Antônio de Arroxelas
Abstract: The etiological elucidation of complex neuropsychiatric and infectious disorders represents a critical challenge within Brazil’s Unified Health System, often resulting in prolonged diagnostic journeys. This study aimed to evaluate the clinical applications of next-generation sequencing through genomic and metagenomic approaches conducted at Fiocruz Ceará in complex clinical cases referred from tertiary care in Fortaleza. The genomic approach (whole-exome sequencing) was applied to a cohort of 17 patients, subdivided into a psychiatric cohort (n=9) and a neurological cohort (n=8), while metagenomics was employed to investigate a case of neuroinfection without confirmatory diagnosis using conventional methods. Concurrently, an operational research component, including a participatory assessment with the technical team, mapped systemic barriers in the diagnostic pathway. Genomic investigation revealed clinically relevant findings across the cohort and enabled the establishment of a highly probable molecular diagnosis in 37.5% of the neurological subcohort with specialized clinical curation, notably highlighting the identification of a rare NIT1 variant in a 50-year-old patient with a history of leukodystrophy. Metagenomic analysis was decisive for the confirmatory diagnosis of progressive multifocal leukoencephalopathy caused by John Cunningham virus in an HIV-positive patient. Operational research quantified barriers, identifying the lack of clinical information as the main communication gap (reported by 100% of the team). These results, integrating clinical and operational evidence, supported the development of a collaborative technical-operational protocol, structured under the Clinical–Wet–Dry model, to integrate next-generation sequencing into Ceará’s health network in articulation with Fiocruz Ceará. In conclusion, the application of next-generation sequencing, when guided by a translational approach, not only substantially increases diagnostic yield but also generates a feasible, evidence-based implementation model for incorporating precision technologies into the healthcare system, with the potential to optimize clinical management and strengthen health surveillance.
Tipo: Dissertação</summary>
    <dc:date>2025-01-01T00:00:00Z</dc:date>
  </entry>
</feed>

